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Membrane-attack complex/perforin (MACPF) proteins are transmembrane
pore-forming proteins that are important in both human immunity and the
virulence of pathogens. Bacterial MACPFs are found in diverse bacterial
species, including most human gut-associated Bacteroides species. The crystal
structure of a bacterial MACPF-domain-containing protein BT_3439
(Bth-MACPF) from B. thetaiotaomicron, a predominant member of the
mammalian intestinal microbiota, has been determined. Bth-MACPF contains
a membrane-attack complex/perforin (MACPF) domain and two novel C-
terminal domains that resemble ribonuclease H and interleukin 8, respectively.
The entire protein adopts a ﬂat crescent shape, characteristic of other MACPF
proteins, that may be important for oligomerization. This Bth-MACPF structure
provides new features and insights not observed in two previous MACPF
structures. Genomic context analysis infers that Bth-MACPF may be involved in
a novel protein-transport or nutrient-uptake system, suggesting an important
role for these MACPF proteins, which were likely to have been inherited from
eukaryotes via horizontal gene transfer, in the adaptation of commensal bacteria
to the host environment.
1. Introduction
Perforin (PF) and components of the membrane-attack complex
(MAC; complement proteins C6–C9) are pore-forming proteins of
the complement part of the innate immune system. They share a
common domain (MACPF) that is also widely distributed in bacteria
and protozoa, including many pathogens (Rosado et al., 2008;
Voskoboinik et al., 2006). Perforin-like proteins in pathogens play an
important role in virulence, for example, by disrupting the plasma
membrane and facilitating parasite exit from host cells (Kafsack et al.,
2009). The recent structures of two MACPF proteins, a bacterial
protein from Photorhabdus luminescens (Plu-MACPF) and the
human complement membrane-attack complex component C8 ,
revealed an unexpected structural similarity to the well studied
cholesterol-dependent cytolysins (CDCs) of many Gram-positive
bacteria, thus suggesting a common mechanism of pore formation
(Hadders et al., 2007; Rosado et al., 2007) by CDC and MACPF. CDCs
form doughnut-shaped pores by the self-polymerization of 30–50
monomers on target membrane surfaces, followed by a major struc-
tural rearrangement and the insertion of two helical regions (Tweten,
2005).
The Gram-negative anaerobic Bacteroides thetaiotaomicron, which
is a predominant member of the human intestinal tract microbiota, is
an important bacterium for the study of the symbiotic relationship
between bacteria and humans (Xu et al., 2003; Hooper & Gordon,
2001). Extracellular proteins are crucial for these functions in
B. thetaiotaomicron and other gut microbes. We initiated a structural
genomics project that aims to determine the structures of proteins
that are unique to the secretome of human gut microbiota in order to
provide broad insights into the molecular mechanisms of bacteria–
host symbiosis and pathogenesis. We have selected proteins that do
not display signiﬁcant similarities to proteins of known structure and
have determined the structures of more than 60 secreted human gut
bacteria proteins thus far. Our structures have revealed that many of
these proteins are distant homologs of well known protein families,which, in many cases, are undetectable based on sequence alone using
even the most sensitive fold-detection algorithms. For example, the
structure of a putative ﬁmbriae assembly protein BT_1062 from B.
thetaiotaomicron (PDB code 3gf8) revealed a fold similar to pili
components of other bacteria despite no detectable sequential simi-
larity (Xu et al., 2010). Similarly, the structure of BVU_2987 (PDB
code 3due) from B. vulgatus uncovered an unexpected similarity in
fold to the  -lactamase inhibitor protein (BLIP; Das et al., 2010).
Therefore, these proteins are also good candidates for exploring the
evolution and divergence of protein structures and the underlying
sequence–structure relationships. Here, we report the crystal struc-
ture of the MACPF protein BT_3439 from B. thetaiotaomicron
(hereafter referred to as Bth-MACPF) at 2.46 A ˚ resolution, which to
our knowledge is the ﬁrst structure of a potential CDC-like toxin
from a gut symbiont.
2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the Polymerase Incomplete Primer
Extension (PIPE) cloning method (Klock et al., 2008). The gene
encoding Bth-MACPF (GenBank NP_812351; Swiss-Prot Q8A267)
was ampliﬁed by polymerase chain reaction (PCR) from B. theta-
iotaomicron VPI-5482 genomic DNA using PfuTurbo DNA poly-
merase (Stratagene) and I-PIPE (Insert) primers (forward primer,
50-ctgtacttccagggcAATGAGGAGGAAACTAATAATTATACTC-30;
reverse primer, 50-ctgtacttccagggcAATGAGGAGGAAACTAATA-
ATTATACTC-30; target sequence in upper case) that included
sequences for the predicted 50 and 30 ends. The expression vector
pSpeedET, which encodes an amino-terminal tobacco etch virus
(TEV) protease-cleavable expression and puriﬁcation tag (MGS-
DKIHHHHHHENLYFQ/G), was PCR-ampliﬁed with V-PIPE
(Vector) primers (forward primer, 50-taacgcgacttaattaactcgtttaaacgg-
tctccagc-30; reverse primer, 50-gccctggaagtacaggttttcgtgatgatgatgatg-
atg-30). The V-PIPE and I-PIPE PCR products were mixed to anneal
the ampliﬁed DNA fragments together. Escherichia coli GeneHogs
(Invitrogen) competent cells were transformed with the I-PIPE/
V-PIPE mixture and dispensed onto selective LB–agar plates. The
cloning junctions were conﬁrmed by DNA sequencing. Using the
PIPE method, the gene segment encoding residues Met1–Thr18 was
excluded from the ﬁnal construct as it was predicted to encode a
signal peptide. Expression was performed in selenomethionine-
containing medium at 310 K. Selenomethionine was incorporated via
inhibition of methionine biosynthesis (Van Duyne et al., 1993), which
does not require a methionine-auxotrophic strain. At the end of
fermentation, lysozyme was added to the culture to a ﬁnal concen-
tration of 250 mgm l
 1 and the cells were harvested and frozen. After
one freeze–thaw cycle, the cells were sonicated in lysis buffer [50 mM
HEPES pH 8.0, 50 mM NaCl, 10 mM imidazole, 1 mM tris(2-
carboxyethyl)phosphine–HCl (TCEP)] and the lysate was clariﬁed by
centrifugation at 32 500g for 30 min. The soluble fraction was passed
over nickel-chelating resin (GE Healthcare) pre-equilibrated with
lysis buffer, the resin was washed with wash buffer [50 mM HEPES
pH 8.0, 300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol, 1 mM
TCEP] and the protein was eluted with elution buffer [20 mM
HEPES pH 8.0, 300 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP].
The eluate was buffer-exchanged with TEV buffer (20 mM HEPES
pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) using a PD-10
column (GE Healthcare) and incubated with 1 mg TEV protease per
15 mg of eluted protein. The protease-treated eluate was run over
nickel-chelating resin (GE Healthcare) pre-equilibrated with HEPES
crystallization buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM
imidazole, 1 mM TCEP) and the resin was washed with the same
buffer. The ﬂowthrough and wash fractions were combined and
concentrated to 19.8 mg ml
 1 by centrifugal ultraﬁltration (Millipore)
for crystallization trials. Bth-MACPF was crystallized by mixing
100 nl protein solution with 100 nl crystallization solution in a sitting
drop over a 50 ml reservoir volume using the nanodroplet vapor-
diffusion method (Santarsiero et al., 2002) with standard JCSG
crystallization protocols (Lesley et al., 2002). The crystallization
reagent consisted of 5%(v/v) 2-methyl-2,4-pentanediol, 12%(v/v)
polyethylene glycol 6000, 0.1 M HEPES pH 6.7. A cube-shaped
crystal of approximate dimensions 40   40   30 mm was harvested
after 42 d at 277 K for data collection. Glycerol was diluted to
10%(v/v) using the reservoir solution and then added to the drop in a
1:1 ratio as a cryoprotectant prior to mounting. Initial screening for
diffraction was carried out using the Stanford Automated Mounting
system (SAM; Cohen et al., 2002) at the Stanford Synchrotron
Radiation Lightsource (SSRL, Menlo Park, California, USA).
The oligomeric state of Bth-MACPF in solution was determined
using a 1   30 cm Superdex 200 size-exclusion column (GE
Healthcare) coupled with miniDAWN static light-scattering (SEC/
SLS) and Optilab differential refractive-index detectors (Wyatt
Technology). The mobile phase consisted of 20 mM Tris–HCl pH 8.0,
150 mM NaCl and 0.02%(w/v) sodium azide. The molecular weight
was calculated using ASTRA v.5.1.5 software (Wyatt Technology).
2.2. Data collection, structure solution, refinement and analysis
Multi-wavelength anomalous diffraction (MAD) data were
collected on beamline 9-2 at the SSRL at wavelengths corresponding
structural communications
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Table 1
Summary of crystal parameters, data-collection and reﬁnement statistics for Bth-
MACPF (PDB code 3kk7).
Values in parentheses are for the highest resolution shell.
 1 MADSe  2 MADSe  3 MADSe
Space group P212121
Unit-cell parameters (A ˚ ) a = 78.4, b = 127.2, c = 138.3
Data collection
Wavelength (A ˚ ) 0.9791 0.9184 0.9792
Resolution range (A ˚ ) 49.4–2.46
(2.59–2.46)
48.0–2.80
(2.95–2.80)
48.0–2.80
(2.95–2.80)
No. of observations 342564 122453 121355
No. of reﬂections 49779 34098 33698
Completeness (%) 97.3 (94.2) 98.2 (98.2) 97.0 (99.7)
Mean I/ (I) 10.6 (2.3) 7.3 (2.0) 8.6 (2.6)
Rmerge on I† 0.123 (0.75) 0.153 (0.69) 0.125 (0.52)
Model and reﬁnement statistics
Resolution range (A ˚ ) 49.4–2.46
No. of reﬂections (total) 49764
No. of reﬂections (test) 2514
Completeness (%) 97.3
Data set used in reﬁnement  1 MADSe
Cutoff criterion |F|>0
Rcryst‡ 0.209
Rfree§ 0.252
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond lengths (A ˚ ) 0.014
Bond angles ( ) 1.47
Average isotropic B value (A ˚ 2) 40.2}
ESU†† based on Rfree (A ˚ ) 0.27
Protein residues/atoms 1001/8046
Solvent molecules 244
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ.‡ Rcryst =
P
hkl
   jFobsj 
jFcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed structure-factor
amplitudes, respectively. § Rfree is the same as Rcryst but for 5% of the total reﬂections
chosen at random and omitted from reﬁnement. } This value represents the total B
that includes TLS and residual B components. †† Estimated standard uncertainty in
coordinates (Collaborative Computational Project, Number 4, 1994; Cruickshank,
1999).to the peak ( 1), high-energy remote ( 2) and inﬂection ( 3) wave-
lengths of a selenium MAD experiment (see Table 1). The data sets
were collected at 100 K using a MAR CCD 325 detector. The MAD
data were integrated and reduced using XDS and scaled with the
program XSCALE (Kabsch, 2010). Selenium sites were located with
SHELXD (Sheldrick, 2008) and reﬁned using autoSHARP (mean
ﬁgure of merit of 0.34 with 22 selenium sites; Bricogne et al., 2003).
Density modiﬁcation was performed by SOLOMON (Abrahams &
Leslie, 1996) and automatic model building was performed by
Buccaneer (Cowtan, 2006). Iterative model building and reﬁnement
structural communications
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Figure 1
Multiple sequence alignment of Bth-MACPF homologs (sequence identity <90%) with the same domain architecture. The sequence numbering and secondary-structure
elements of Bth-MACPFare shown at the top and domain boundaries ({) and sequence motifs are shown at the bottom. Charged residues are highlighted in red (negative)
and blue (positive), hydrophobic residues in green and hydrophilic residues in yellow. The following sequences are shown: b.th1, B. thetaiotaomicron BT_3439 (Bth-
MACPF); b.sp, Bacteroides sp. 2_2_4 (UniProt accession C3QVE5); b.th2, B. thetaiotaomicron BT_3437; b.pl, B. plebeius DSM 17135 (UniProt accession B5CX96); p.en, P.
endodontalis ATCC 35406 (UniProt accession C3J7W9).were performed with Coot (Emsley & Cowtan, 2004) and REFMAC
(Winn et al., 2003), respectively. The reﬁnement included experi-
mental phase restraints in the form of Hendrickson–Lattman coefﬁ-
cients and TLS reﬁnement with four TLS groups per chain (residues
36–56, 66–389, 390–493 and 494–558). CCP4 programs were used for
data conversion and other calculations (Collaborative Computational
Project, Number 4, 1994). Data-processing and reﬁnement statistics
are summarized in Table 1. The quality of the crystal structure was
evaluated using MolProbity (Chen et al., 2010) and WHAT IF
(Vriend, 1990). HHpredict was used for protein-homology detection
and function prediction (Soding et al., 2005). Signal peptides were
analyzed using SignalP (Emanuelsson et al., 2007) and LipoP
(Juncker et al., 2003). Oligomers of Bth-MACPF with C16 symmetry
were predicted using SymmDOCK (Schneidman-Duhovny et al.,
2005). Molecular graphics were prepared with PyMOL (DeLano
Scientiﬁc). Sequence alignments were rendered using TEXshade
(Beitz, 2000).
3. Results and discussion
3.1. Bioinformatics analysis
MACPF domains are widely distributed in eukaryotes, but are
sporadic in bacteria. Only  40 bacterial MACPF proteins are
cataloged in the PFAM database (PF01823; Bateman et al., 2004).
Chlamydiaceae contain 13 closely related MACPF proteins (Ponting,
1999). Bacteroides contain about a third of all bacterial MACPF
proteins. The others are found in diverse bacterial species from
proteobacteria, actinomycetales and cyanobacteria. It has been
suggested that these proteins were acquired from eukaryotes through
horizontal gene transfer in order to adapt to the intracellular
environment of the host (Ponting, 1999; Wolf et al., 1999). Preliminary
phylogenetic analysis (data not shown) suggests that the
Bacteroidetes branch is likely to represent an independent horizontal
gene-transfer event. Thus, MACPFs in the human gut microbiome
may play an important role in the symbiotic relationship, but their
speciﬁc functions are currently unknown.
Bacterial MACPFs are highly divergent in sequence and domain
architecture. Homologs that have signiﬁcant similarity over the entire
sequence of Bth-MACPF are found mostly in other human-related
Bacteroidetes, including unclassiﬁed Bacteroides sp. (strains 2_1_22,
2_2_4 and D1), B. fragilis 3_1_12 (Bfra3_17507), B. plebeius DSM
17135(BACPLE_01336),B.intestinalisDSM17393 (BACINT_00423)
and Porphyromonas endodontalis ATCC 35406 (POREN0001_1212)
(Fig. 1), but also in the recently sequenced deep-sea Zunongwangia
profunda SM-A87 (ZPR_2061). MACPFs from Bacteroides are
unique as most of them contain lipoprotein signal peptides (Juncker
et al., 2003) that are not present in other bacterial MACPFs.
B. thetaiotaomicron contains two homologous MACPFs (BT_3439
and BT_3437; 33% sequence identity) that are likely to form part of
an operon (see more detailed discussion below), as well as a third
more distant paralog (BT_3120) that consists of only an MACPF
domain. B. fragilis YCH46 (BF1566, BF1634 and BF2685) and
B. intestinalis DSM 17393 (BACINT_00423, BACINT_00829 and
BACINT_03190) each contain three MACPFs, with only one protein
in each species having the same domain architecture as Bth-MACPF.
Bth-MACPFis located among a cluster of uncharacterized proteins
(BT_3442 to BT_3433) that form a putative operon and which are
located directly downstream of a well deﬁned operon of cell-division
and cell-wall biosynthesis proteins such as FtsZ, FtsA, FtsQ and
MurC. This cluster, which appears to contain internal duplications
resulting in three homologous pairs (BT_3436/BT_3438, BT_3437/
BT_3439 and BT_3433/BT_3440), is rich in potential pore-forming
proteins (BT_3433, BT_3434, BT_3437, BT_3439 and BT_3440).
Most of the proteins in the cluster also contain similar lipoprotein
signal peptides (Fig. 2), suggesting that they are localized to a
common area in the cell. BT_3433 and BT_3440 are likely to have a
trefoil fold resembling that of hemolytic pore-forming lectins
(Mancheno et al., 2005). BT_3434 is likely to be an outer membrane
porin, while BT_3435 is a putative inner membrane protein with
three transmembrane helices. BT_3441 is a homolog of a hypothetical
protein BVU_0276 from B. vulgatus, the structure of which has also
been determined by the JCSG (PDB code 3d33). It has an immu-
noglobulin-like fold that is common in cell-surface proteins such as
ﬁbronectin and complement C3. BT_3442 is a multi-domain protein
containing TPR motifs, which often mediate protein interaction.
Therefore, Bth-MACPF is associated with several pore-forming
proteins, suggesting a possible role in a cross-membrane transport
system. The association of Bacteroides MACPFs with lipoproteins
and outer membrane porins is also observed in B. fragilis YCH46
(Fig. 2).
Bth-MACPF was predicted to be an extracellular protein by
PSORTb (Gardy et al., 2005) and SOSUIGramN (Imai et al., 2008).
The N-terminal region of Bth-MACPF (
1MKKLFISLCIILFTISC
17)
matches the lipoprotein signal peptide pattern of Gram-negative
bacteria, which usually consists of one or more positive charged
residues followed by a stretch of hydrophobic residues and a lipobox
motif L(A/S)(G/A)C (Hayashi & Wu, 1990). Similar lipoprotein
structural communications
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Figure 2
Genomic context of MACPF proteins in two completed genomes of Bacteroides: B. thetaiotaomicron (Bth) and B. fragilis YCH46 (Bfr). Predicted lipoproteins are shown as
red boxes. Proteins containing other signal peptides are colored cyan. The locus number of each gene is shown at the top. IM, inner membrane protein; OM, outer membrane
protein; DUF, domain of unknown function; TPR, protein containing tetratricopeptide repeats.signal peptides are also present in structural subunits of the major
and minor ﬁmbriae FimA and Mfa1 of P. gingivalis, which is a close
phylogenetic relative of B. thetaiotaomicron, suggesting a common
mechanism of translocation across the membrane (Shoji et al., 2004).
Lipoproteins are transported across the inner membrane by the
general secretion pathway. On the periplasmic face of the inner
membrane, the invariant cysteine residue is modiﬁed by the diacyl-
glyceryl transferase (Lgt), followed by cleavage of the peptide before
the diacylglyceride cysteine by signal peptidase II (LspA) and further
modiﬁcation of the diacylglyceride cysteine by aminoacyl transferase
(Lnt; Tokuda, 2009). These proteins are then sorted to their ﬁnal
destinations, but the details of the ﬁnal steps of translocation of
extracellular lipoproteins in Bacteroides are currently not clear. The
ﬁnal products could either be tethered to the outer membrane or
cleaved and released to the extracellular medium and may be
dependent on other residues in close proximity to the cysteine (e.g.
the conserved acidic residue at position +4; Fig. 1).
3.2. Structural determination
The BT_3439 gene of B. thetaiotaomicron encodes a predicted
lipoprotein with a molecular weight of 63 425 Da (residues 1–558)
and a calculated isoelectric point of 5.5. We determined the structure
using the high-throughput pipeline of the Joint Center for Structural
Genomics (JCSG; Lesley et al., 2002) as part of the National Institute
of General Medical Sciences’ Protein Structure Initiative (PSI;
http://www.nigms.nih.gov/Initiatives/PSI/). A selenomethionine
derivative of Bth-MACPF was expressed in E.coli with an N-terminal
TEV-cleavable His tag and was puriﬁed by metal-afﬁnity chromato-
graphy. To improve the likelihood of obtaining crystals, the predicted
N-terminal signal peptide (residues 1–18) was not included in the
clone construct. The data were indexed in the orthorhombic
space group P212121 and the structure was determined at 2.46 A ˚
resolution with two molecules per asymmetric unit using the MAD
method. The structure was reﬁned to a ﬁnal R factor of 20.9% and an
Rfree of 25.2%. The model of Bth-MACPF displays good geometry,
with an all-atom clash score of 7.8, and the Ramachandran plot
produced by MolProbity (Chen et al., 2010) shows that all residues
are in allowed regions, with 96.7% in favored regions. The ﬁnal model
of Bth-MACPF contains residues A/B36–558, 239 waters and other
solvent molecules that were present in the crystallization or cryo-
protection reagents, including one MPD [(4S)-2-methyl-2,4-penta-
nediol] molecule, one chloride ion and three ethylene glycol
molecules. The residual residue (Gly0) from the cleaved N-terminal
puriﬁcation tag and segments A/B19–35, A/B57–65, A277–286, B272–
286 and A482–483 were not included in the model owing to a lack
of interpretable electron density. Additionally, side chains for 17
residues were only partially modeled owing to disorder. Data-
collection, reﬁnement and model statistics are summarized in
Table 1.
3.3. Overall structure
Bth-MACPF (Fig. 3) adopts a ﬂat crescent shape with molecular
dimensions of 93   58   44 A ˚ . The two monomers in the asymmetric
unit are nearly identical (with an overall r.m.s.d. of 0.67 A ˚ for 493 C
 
atoms) with larger deviations located at the two tips, mostly owing to
a slight opening of the crescent in molecule B compared with
molecule A. Bth-MACPF consists of three structured domains: an
MACPF domain (residues 66–389) and two C-terminal domains, D2
structural communications
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Figure 3
Crystal structure of Bth-MACPF. (a and b) Ribbon representations of Bth-MACPF in orthogonal views. The color scheme is as follows: the extended N-terminal region is
shown in blue, the MACPF domain in shown in green with TMHs in red and the MACPF motif in magenta, domain D2 is shown in cyan and domain D3 is shown in orange.
The  -sheets (A–E) and helices (A–N) are labeled alphabetically as in Fig. 1; 310-helices are not labeled. (c) Surface representation of Bth-MACPF color coded by domain as
in (a and b).(residues 390–492) and D3 (residues 493–558) (Figs. 3a and 3b).
Residues 36–56 of the N-terminus of Bth-MACPFadopt an extended
conformation and pack against parts of the MACPF (residues 388–
392), D2 (residues 449–474) and D3 (residues 523–531) domains with
a total buried surface area of 2029 A ˚ 2 (Fig. 3b). The interface contains
32 hydrogen bonds and helps to maintain overall structural integrity.
This arrangement places the predicted N-terminal membrane-
attachment site (Cys18) away from the MACPF domain. The
remaining N-terminal residues that were included in the construct
(residues 19–35 and 57–65) were not observed in the electron density
and are most likely to be ﬂexible in solution. Furthermore, Bth-
MACPF is likely to be a monomer in solution, as supported by
crystal-packing analysis and analytical size-exclusion chromato-
graphy (data not shown).
The MACPF domain contains two four-stranded  -sheets (A and
B) in the central core, which is decorated by several helical insertions.
The A sheet with its short strands (strand order 2134) and the B sheet
with long strands (strand order 1234) assemble to form a twisted S
shape. The B sheet itself is very distorted and bends fairly abruptly in
the middle by  90 . This arrangement of central  -sheets with
characteristic geometry is common to both MACPFs and CDCs and
allowed the classiﬁcation of MACPF and CDC into a single family
(Rosado et al., 2007; Hadders et al., 2007). The last strand of the B
sheet is interrupted (strands 4 and 40) by an insertion (residues 316–
350) at the bend of the sheet. Insertions between  1– 2 and  3– 4
(TMH1 and TMH2, respectively) correspond to the so-called TMH
regions of CDCs, which unfold and form transmembrane  -hairpins.
TMH1 (residues 126–173) contains one helix ( B) and two short
310-helices that pack against the inner surface of the B sheet. TMH2
(residues 248–304) contains an antiparallel   –   structure that sits
on the outer surface of the B sheet. The two strands in TMH2 and
another strand from the 4–40 (B-sheet) insertion forms another
 -sheet (C sheet) parallel to the B sheet. The MACPF motif Y/W-G-
T/S-H-F/Y-X6-GG (Ponting, 1999; Rosado et al., 2007) is located on
strands 3A and 3B (Fig. 3a). The corresponding Bth-MACPF region
(
225YGEFVX6GG
237) is more divergent from the consensus, with
nonconserved changes at positions 3–5. Two glycines from the
MACPF motif (Gly236 and Gly237) and two additional nearby
conserved glycines (Gly316 and Gly317; Figs. 1 and 3) are likely to be
essential for structural ﬂexibility in MACPFand CDC (Rosado et al.,
2007).
The A sheet is crowned by four helices:  I and a three-helix
insertion ( C– E) between  2B ( 2 of the B sheet) and  3A. These
helices form the interface between the MACPF and D2/D3 domains.
Both D2 and D3 are layered structures with a central  -sheet pro-
tected by helices on two sides (see below). The D2 and MACPF
interface involves interaction between  D and  I of MACPFand the
 3– 4 and  5– 6 loops of D2 and buries a surface area of  1000 A ˚ 2
(500 A ˚ 2 each). The interface is mostly hydrophilic. In particular, a
buried Asp423 in D2 forms a bifurcated hydrogen bond to Arg375 of
MACPF. D3 functions as a wedge between D2 and MACPF, with a
similar interface area on either side (total  1400 A ˚ 2 for D3). Leu558
is buried with its C-terminal carboxyl group forming a hydrogen-
bond network involving the conserved residues Arg420 and Tyr530.
Additionally, the interaction between domains is further stabilized by
the N-terminal extended region (residues 36–56) described above.
Gap-volume indices between these interacting components are less
than 1.7, which is consistent with the expected average (1.8) for
intrachain domain–domain interfaces (Jones et al., 2000). Thus, we
conclude that the domain arrangement observed in the crystal
structure is likely to be representative of the functional protein and
not a crystallization artifact.
3.4. D2 and D3 domains
The MACPF domain is usually attached to other auxiliary domains
that are expected to regulate the function of MACPF. As discussed
earlier, both C-terminal domains of Bth-MACPFare only detected in
its closest homologs in sequence-similarity searches (Fig. 1). The D2
and D3 domains show some structural similarity: both have an  / 
fold with       topology. However, most structural comparison
programs fail to recognize this similarity and also fail to identify
signiﬁcant similarities to other proteins. The       core of D2 and
D3 can be partly matched to other structures (Fig. 4), for instance to
proteins with the YegP-like fold (SCOP ID 160112), which is char-
acterized by an internal repeat of two domains with a       core.
Other examples include the connector domain (residues 321–431;
PDB code 1mu2; Ren et al., 2002) of HIV reverse transcriptase (Z =
3.6; r.m.s.d. 3.3 A ˚ for 68 aligned C
  atoms; sequence identity 6%),
which is likely to have evolved from the ribonuclease H domain
(Malik & Eickbush, 2001; Fig. 4a). However, the C-terminal portions
of the two structures differ signiﬁcantly. Domain D3 is similar, for
instance, to a viral chemokine (PDB code 1zxt; Luz et al., 2005), with
an r.m.s.d. of 2.2 A ˚ (sequence identity 5%) for 44 C
  atoms (Fig. 4b).
Chemokines adopt a      interleukin 8-like structure stabilized by
two conserved disulﬁde bonds. D3 lacks the long cysteine-containing
N-terminal portion observed in chemokines. Instead, it contains an
   C-terminal extension and forms a         overall structure. The
      motif is most likely to represent a repeated structural unit that
can be found in nonhomologous proteins with different functions,
thus limiting the interpretation of structural similarity in terms of
common function.
3.5. Homology of MACPF domains
The MACPF domain in Bth-MACPF is homologous to human
MACPFs, as indicated by the signiﬁcant sequence similarity recog-
nized, for instance, by FFAS (Jaroszewski et al., 2005) and HHpredict
(Hildebrand et al., 2009) and by three-dimensional structural simi-
larity using the DALI server (Holm & Sander, 1995). The ﬁrst two
DALI hits are the only two previously determined MACPF struc-
tures: Plu-MACPF (PDB code 2qp2; Rosado et al., 2007) and the C8 
MACPF domain (PDB codes 2qqh and 2rd7; Hadders et al., 2007;
Slade et al., 2008). Bth-MACPF is most similar to Plu-MACPF, with a
Z score of 17.4, which corresponds to an r.m.s.d. of 3.8 A ˚ and 16%
sequence identity for 247 aligned C
  atoms. The second hit, human
C8  (PDB code 2qqh), can be superimposed onto Bth-MACPF with
218 aligned C
  atoms, an r.m.s.d. of 5.0 A ˚ and 14% sequence identity
(Z = 12.3). More distant similarity is also apparent between Bth-
MACPF and CDCs, such as the thiol-activated cytolysin perfringo-
lysin O (PFO; PDB code 1m3i; Rossjohn et al., 1997; Z = 7.2, r.m.s.d.
5.2 A ˚ and 11% sequence identity for 198 aligned C
  atoms). The
structural similarity between MACPF domains and the CDC family
of toxins has previously been noted, which led to the proposal that
MACPF domains use a CDC-like mechanism for pore formation
(Rosado et al., 2007; Hadders et al., 2007). In this model, TMH1 and
TMH2 undergo conformational changes to form antiparallel hairpins
so that the extended  -sheet can oligomerize through the open edges
of  1 and  4.
The similarity between the three MACPF domains is even more
signiﬁcant at the topological level (Fig. 5). All contain a common core
consisting of sheet A and sheet B. Various insertions occur at speciﬁc
locations in the conserved strands, most notably between  2A and
 1B,  4B and  4B0,  1B and  2B (TMH1),  3B and  4B (TMH2)
and  2B and  3A. One common helix within the  4B– 4B0 insertion
( H of Bth-MACPF) is conserved in all known MACPFs and harbors
structural communications
1302 Xu et al.   MACPF family protein Acta Cryst. (2010). F66, 1297–1305several highly conserved residues (e.g. Trp340) that interact with the
region containing the critical glycines that were discussed above. The
 4B– 4B0 insertion in Bth-MACPF contains two additional short
strands that augment the B sheet and the C sheet, respectively. As a
result, this insertion in Bth-MACPF is more similar to PFO. The
additional short  -strand in the B sheet of CDCs ( 5B in Bth-
MACPF) prevents premature oligomerization by blocking access to
 4 (Ramachandran et al., 2004). The  -hairpin insertion between  2A
and  1B of the C8  MACPF domain and Plu-MACPF are replaced
by one helix ( A) and a 310-helix in Bth-MACPF. This region of C8 
is involved in the interaction with the C8  subunit (Slade et al., 2008).
The TMH regions of MACPFs and CDCs are generally not conserved
in sequence (Rosado et al., 2007). TMHs of Bth-MACPF contain
short stretches of amphipathic regions which might be important for
forming transmembrane hairpins (Fig. 1). Both TMHs of Bth-
MACPF (48 and 57 amino acids) are longer than the TMHs of CDCs,
which generally consist of  30 amino acids. Longer TMH regions
( 60 amino acids) are also observed in C8 , C9 and perforin and are
likely to be a general feature of MACPF. C8  and Bth-MACPF both
contain an   –   hairpin, but in different locations (TMH1 in C8 
and TMH2 in Bth-MACPF). Interestingly, the two faces of the B
sheet in all three MACPFs display amphipathic properties. The
interface between the B sheet and TMH1 is mostly polar, whereas the
TMH2 interface is more tightly packed and hydrophobic (Fig. 5).
3.6. Functional implications
The helical insertion between  2B and  3A is involved in docking
the D2 and D3 domains to the Bth-MACPF domain. These helices
are also present in Plu-MACPF and C8  MACPF, but are currently
not implicated in protein–protein interactions. Both Plu-MACPFand
Bth-MACPF contain additional C-terminal domains. However, the
locations of these domains are completely different. The C-terminal
 -prism domain of Plu-MACPF is located on the opposite side of the
central core (left corner of lower ﬁgure of Plu-MACPF in Fig. 5)
compared with D2 and D3 (upper left corner) in Bth-MACPF. The
arrangements of these auxiliary domains may reﬂect their different
roles. The  -prism domain of Plu-MACPF is similarly located
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Figure 4
Structural comparisons of the D2 and D3 domains. (a) Structural comparison between D2 and the connector domain of HIV reverse transcriptase (PDB code 1mu2). (b)
Structural comparison between D3 and a viral chemokine (PDB code 1zxt). Equivalent C
  atoms are shown in red.compared with domain 4 of PFO and may interact with the
membrane directly (Rosado et al., 2007). In contrast, D2 and D3 of
Bth-MACPF, which are distant from the TMH regions, seem more
likely to play a role in protein–protein interaction (e.g. polymeriza-
tion or interaction with BT_3442) rather than membrane attachment.
The shape of Bth-MACPF appears to be self-complementary, which
could facilitate ring-like self-assembly (Hadders et al., 2007) to form
pores across membranes. Modeling studies suggest that it is feasible
for Bth-MACPF to polymerize via the C-terminal auxiliary domains.
A model with 16 copies of Bth-MACPF forms a doughnut-shaped
molecule with an inner radius of 110 A ˚ , similar in pore size to the the
C9 MACPF model (Hadders et al., 2007). The multimer interface
involves docking a helical wedge from D2 and D3 (helices K, L and
M) into the D2–MACPF interface (D sheet and helix I). The
formation of protein complexes involving Bth-MACPF may facilitate
structural changes in the MACPF domain which are necessary to
form the porin-like transmembrane pore.
MACPFs are well known for killing cells by forming pores and thus
are potential virulence factors. Here, we demonstrate the existence
of a novel subfamily of secreted MACPF proteins in commensal
bacteria. Unfortunately, the physiological functions of these proteins
are currently unknown. The properties of the MACPF/CDC fold,
such as structural ﬂexibility and membrane penetration, may be
utilized for nonlytic purposes (Rosado et al., 2007) and Bth-MACPF
may be involved in novel protein-secretion or nutrient-uptake
systems. Alternatively, MACPFs may protect the bacteria from host
immunity through molecular mimicry (Stebbins & Galan, 2001;
Kohm et al., 2003). For example, the presence of these molecules
on the cell surface may prevent the assembly of the host MACPF
complex. Another possibility is that MACPFs may function as
potential toxins, such as bacteriocins against Gram-positive bacteria.
Bacteriocins are often produced by nonpathogenic bacteria that
colonize the human body and may help to prevent infection by
opportunistic pathogenic bacteria. Furthermore, it remains possible
structural communications
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Figure 5
Structural comparison of the MACPF domains in Bth-MACPF, Plu-MACPF and C8 . Top: comparison of the secondary-structure topology diagrams of MACPF domains
(sheet A, yellow; sheet B, cyan; TMHs, red). Bottom: ribbon representation of MACPF proteins in the same orientation and color coded as in the topology diagrams.that these bacterial MACPFs are virulence factors towards the host
under certain conditions, as gut symbionts, such as B. fragilis, are also
opportunistic pathogens. It is well documented that many bacterial
virulence-factor genes are located within genomic islands (Juhas et al.,
2009). The clustering of potential pore-forming outer-membrane
toxins in the B. thetaiotaomicron genome suggest that this region
could be a pathogenicity island acquired through horizontal gene
transfer, as predicted by a genome-wide genomic islands study (Ho
Sui et al., 2009).
Although the functions of the MACPFs represented by Bth-
MACPF remain to be elucidated, our study provided clues that they
are important targets for further exploration of how symbiotic
microbes adapt to and inﬂuence their host environments. Additional
information about the proteins described in this study is available
from TOPSAN (Krishna et al., 2010) at http://www.topsan.org/
explore?PDBid=3kk7.
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